Izidakamizwa zenuzi ukukhomba nokuqeda umdlavuza obala imibala

Yabelana ngalokhu okuthunyelwe

Abaphenyi ku- I-Memorial Sloan Kettering Cancer Center kanye neMassachusetts Institute of Technology benze uhlelo olusha olunezinyathelo ezintathu olusebenzisa izidakamizwa zenuzi ukukhomba nokuqeda umdlavuza we-colorectal. Abacwaningi bathole isilinganiso sokwelapha esingu-100% kumodeli yegundane futhi abazange babe nemithelela enobuthi ehlobene nokwelashwa . Umbiko wocwaningo ushicilelwe ku-November Journal of Nuclear Medicine.

Kuze kube manje, i-radioimmunotherapy (ukwelashwa okuhlosiwe) kusetshenziswa ama-radionuclide aqondiswe ku-antibody ukwelapha izimila eziqinile inamandla alinganiselwe. “Lolu wucwaningo lwamanoveli. Kuyimisebe yesibili engeyona enobuthi ezicutshini ezijwayelekile zomzimba womuntu ekwelapheni umthamo wesimila. ” Steven m. U-Larson noDkt. Sarah Cheal bachaza, “Impumelelo yemodeli yesimila segundane ivela eqenjini Ikhwalithi eyingqayizivele yama-reagents athuthukisiwe, ngakolunye uhlangothi, isukela ezindleleni zokuzilolonga ezincishisiwe, okuhlanganisa indlela yokwelapha yokwelapha engadluliselwa kalula iziguli. “Le ndlela isebenzisa umuthi owodwa ukuhlola nokwelapha izifo. Umuthi uqale uthole amangqamuzana omdlavuza bese uwabhubhisa ukuze amaseli anempilo angalimali. Ngale ndlela, imiphumela engemihle iyancishiswa futhi izinga lempilo yesiguli liyathuthukiswa.

In this study, glycoprotein A33 (GPA33) was used to recognize A33 tumor antigen. DOTA-pretargeted radioimmunotherapy (PRIT) was tested on a mouse model. For randomly selected test mice, SPECT / CT imaging was used to monitor the treatment response, and the radiation absorbed dose of the tumor was calculated. The tested mice responded well. None of the evaluated mice showed signs of cancer under the microscope, and no significant radiation damage was seen in key organs including bone marrow and kidney.

Izinga lokwelapha elingu-100% kumodeli yegundane liwukuthola okwamukelekayo, okubonisa ukuthi i-anti-GPA33-DOTA-PRIT izoba uhlobo olusebenzayo lwe-radioimmunotherapy ku-GPA33-positive colorectal regimen.

Ngokusho kwe-CDC, umdlavuza we-colorectal ungumdlavuza wesithathu ovame kakhulu othinta amadoda nabesifazane. E-United States, cishe kunamacala amasha ayi-140,000 unyaka ngamunye nokufa kwabantu abangama-50,000.

U-Larson no-Cheal bakholelwa ukuthi uma impumelelo yomtholampilo ifinyelelwa, lokhu kwelashwa kwezikhali zenuzi kunganwetshwa nakwamanye umdlavuza. Uhlelo luklanywe njengohlelo “lokuxhumanisa nokudlala” olungamukela izinhlobonhlobo zamasosha omzimba ngokumelene nama-antigen wesimila somuntu, futhi ngokomgomo lusebenza kuzo zonke izimila eziqinile neziwuketshezi emzimbeni womuntu. Bangeze ngokuthi “umkhakha we-oncology, ikakhulukazi izimila ezihlukahlukene eziqinile ezihlanganisa ikholoni, ibele, amanyikwe, i-melanoma, amaphaphu nommizo, kunesidingo esikhulu sokwelashwa kwezifo ezithuthukile.” 

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell
Ukwelashwa kwe-CAR T-Cell

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell

Abezimo eziphuthumayo badlala indima ebalulekile empumelelweni yokwelashwa kwe-CAR T-cell ngokuqinisekisa ukunakekelwa kwesiguli okungenamthungo kuyo yonke inqubo yokwelashwa. Banikeza ukwesekwa okubalulekile ngesikhathi sokuthutha, ukuqapha izimpawu ezibalulekile zeziguli, nokuphatha ukungenelela kwezokwelapha eziphuthumayo uma izinkinga ziphakama. Ukusabela kwabo okusheshayo kanye nokunakekelwa kochwepheshe kunomthelela ekuphepheni okuphelele nasekusebenzeni ngempumelelo kokwelashwa, kusiza uguquko olushelelayo phakathi kwezilungiselelo zokunakekelwa kwezempilo kanye nokwenza ngcono imiphumela yesiguli endaweni eyinselele yezindlela zokwelapha ezithuthukisiwe zamaselula.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton